BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15162052)

  • 1. Investigations into the biological relevance of in vitro clastogenic and aneugenic activity.
    Parry JM; Fowler P; Quick E; Parry EM
    Cytogenet Genome Res; 2004; 104(1-4):283-8. PubMed ID: 15162052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indication for thresholds of chromosome non-disjunction versus chromosome lagging induced by spindle inhibitors in vitro in human lymphocytes.
    Elhajouji A; Tibaldi F; Kirsch-Volders M
    Mutagenesis; 1997 May; 12(3):133-40. PubMed ID: 9175637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotoxicity of several clinically used topoisomerase II inhibitors.
    Boos G; Stopper H
    Toxicol Lett; 2000 Jul; 116(1-2):7-16. PubMed ID: 10906417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of c-fos, c-jun, junB and junD mRNA and AP-1 by alkylating mutagens in cells deficient and proficient for the DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT) and its relationship to cell death, mutation induction and chromosomal instability.
    Dosch J; Kaina B
    Oncogene; 1996 Nov; 13(9):1927-35. PubMed ID: 8934539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indications for a threshold of chemically-induced aneuploidy in vitro in human lymphocytes.
    Elhajouji A; Van Hummelen P; Kirsch-Volders M
    Environ Mol Mutagen; 1995; 26(4):292-304. PubMed ID: 8575418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etoposide and merbarone are clastogenic and aneugenic in the mouse bone marrow micronucleus test complemented by fluorescence in situ hybridization with the mouse minor satellite DNA probe.
    Attia SM; Kliesch U; Schriever-Schwemmer G; Badary OA; Hamada FM; Adler ID
    Environ Mol Mutagen; 2003; 41(2):99-103. PubMed ID: 12605378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic influences for mutation induction curves after exposure to DNA-reactive carcinogens.
    Doak SH; Jenkins GJ; Johnson GE; Quick E; Parry EM; Parry JM
    Cancer Res; 2007 Apr; 67(8):3904-11. PubMed ID: 17440105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of CDKN1A/p21 gene for class discrimination of DNA damage-induced clastogenicity.
    Sakai R; Kondo C; Oka H; Miyajima H; Kubo K; Uehara T
    Toxicology; 2014 Jan; 315():8-16. PubMed ID: 24211769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic risk assessment of etoposide from mouse bone marrow.
    Choudhury RC; Palo AK; Sahu P
    J Appl Toxicol; 2004; 24(2):115-22. PubMed ID: 15052606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotoxicity of flubendazole and its metabolites in vitro and the impact of a new formulation on in vivo aneugenicity.
    Tweats DJ; Johnson GE; Scandale I; Whitwell J; Evans DB
    Mutagenesis; 2016 May; 31(3):309-21. PubMed ID: 26443851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insensitivity of the in vitro cytokinesis-block micronucleus assay with human lymphocytes for the detection of DNA damage present at the start of the cell culture.
    Speit G; Linsenmeyer R; Schütz P; Kuehner S
    Mutagenesis; 2012 Nov; 27(6):743-7. PubMed ID: 22869611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo extrapolations of genotoxin exposures: consideration of factors which influence dose-response thresholds.
    Parry JM; Jenkins GJ; Haddad F; Bourner R; Parry EM
    Mutat Res; 2000 Jan; 464(1):53-63. PubMed ID: 10633177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approaches for characterizing threshold dose-response relationships for DNA-damage pathways involved in carcinogenicity in vivo and micronuclei formation in vitro.
    Clewell RA; Andersen ME
    Mutagenesis; 2016 May; 31(3):333-40. PubMed ID: 26846943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X-rays, microwaves and vinyl chloride monomer: their clastogenic and aneugenic activity, using the micronucleus assay on human lymphocytes.
    Fucić A; Garaj-Vrhovac V; Skara M; Dimitrovic B
    Mutat Res; 1992 Aug; 282(4):265-71. PubMed ID: 1379689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Micronuclei in neonatal lymphocytes treated with the topoisomerase II inhibitors amsacrine and etoposide.
    Slavotinek A; Perry PE; Sumner AT
    Mutat Res; 1993 Nov; 319(3):215-22. PubMed ID: 7694143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micronucleus induction by neocarzinostatin and methyl methanesulfonate in ionizing radiation--sensitive Chinese hamster V79 cell mutants.
    Stopper H; Full M; Helbig R; Speit G
    Mutat Res; 1997 Mar; 383(2):107-12. PubMed ID: 9088343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and characterization of mechanisms of action of aneugenic chemicals.
    Parry EM; Parry JM; Corso C; Doherty A; Haddad F; Hermine TF; Johnson G; Kayani M; Quick E; Warr T; Williamson J
    Mutagenesis; 2002 Nov; 17(6):509-21. PubMed ID: 12435848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different types of combination effects for the induction of micronuclei in mouse lymphoma cells by binary mixtures of the genotoxic agents MMS, MNU, and genistein.
    Lutz WK; Tiedge O; Lutz RW; Stopper H
    Toxicol Sci; 2005 Aug; 86(2):318-23. PubMed ID: 15901918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of a whole chromosome loss by colcemid in human cells elucidated by discrimination between FISH signal overlap and chromosome loss.
    Yamamoto M; Wakata A; Aoki Y; Miyamae Y; Kodama S
    Mutat Res; 2013 Sep; 749(1-2):39-48. PubMed ID: 23792192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of fluorescence in situ hybridisation to study the relationship between cytotoxicity, chromosome aberrations, and changes in chromosome number after treatment with the topoisomerase II inhibitor amsacrine.
    Ferguson LR; Whiteside G; Holdaway KM; Baguley BC
    Environ Mol Mutagen; 1996; 27(4):255-62. PubMed ID: 8665870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.